Abstract:

The Rifampicin-resistant Pulmonary Tuberculosis Diagnostic Process is a group standard issued by Chinese Antituberculosis Association on May 12, 2021 and implemented since then. The standard specifies the diagnostic algorithms of rifampicin resistant pulmonary tuberculosis patients under different technical conditions: the drug resistance diagnosis process of traditional drug sensitivity detection technology, the drug resistance diagnostic progress of combination of molecular biology drug resistance detection technology and traditional drug sensitivity detection technology, multi-color nested real-time fluorescence quantitative PCR, molecular biology drug resistance detection technology and drug resistance diagnosis process of combination of traditional drug sensitivity detection technology. The main contents and applicable conditions of this standard are hereby interpreted.

Key words: Rifampin, Tuberculosis,bacterial, Drug resistance,bacterial, Consensus development conference